Clinical Trials
12 trialsNCT00720304 2024-08-22
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00387530 2019-08-02
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
University of California, San Diego
Phase 2 Withdrawn
NCT00498953 2018-07-09
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT01194635 2017-05-17
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Eastern Cooperative Oncology Group
Completed
NCT01619618 2017-05-17
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
Eastern Cooperative Oncology Group
Completed
NCT00482872 2017-03-14
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
Vanderbilt University Medical Center
Completed
NCT00897988 2017-03-14
DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
Vanderbilt University Medical Center
Completed
NCT00012168 2016-03-11
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
NYU Langone Health
Phase NA Completed
NCT00316823 2014-02-24
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
National Cancer Institute (NCI)
Phase NA Completed
NCT00898664 2013-04-02
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Completed
NCT00690872 2009-06-29
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown